Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-25T08:53:25.753Z Has data issue: false hasContentIssue false
  • English
  • Français

Toxicity of lofepramine and fluvoxamine in heart disease

Published online by Cambridge University Press:  13 June 2014

Colm Cooney  and
Mark Barber
Mark Barber
Affiliation:
Department of Old Age Psychiatry, John Connolly Wing, St. Bernard's Hospital, Southall, Middlesex UB1 3EU, England
Get access Rights & Permissions [Opens in a new window]

Abstract

Therapeutic doses of lofepramine and fluvoxamine were associated with the development of first degree and second degree heart block, respectively, in an 83 year old man with a normal ECG prior to treatment and with no history of cardiovascular disease. Caution is recommended in treating patients with newer generation antidepressants, even in cases where cardiac status appears normal prior to treatment.

Keywords

LofepramineFluvoxamineHeart block
Type
Brief Reports
Information
Irish Journal of Psychological Medicine , Volume 11 , Issue 4 , December 1994 , pp. 164 - 165
Copyright
Copyright © Cambridge University Press 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Gerson, SC, Plotkin, DA, Jarvik, LF. Antidepressant drug studies 1964 to 1986: empirical evidence fore ageing patients. J Clin Pharmacol 1988; 8:311–22Google Scholar
2.Foltyn, P. The treatment of depressive conditions in elderly patient. Arztliche Praxis 1979; 96:3963.Google Scholar
3.Gokelma, Y. Heart effects of lofepramine in depressed patients with or without heart disease. 1983. Presented at the VII World Congress of Psychiatry, Vienna.Google Scholar
4.Roos, JC. Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine. Br J Clin Pharmacol 1983; 15:439s–45s.CrossRefGoogle ScholarPubMed
5.Prager, , et al. Cardiotropic effects of antidepressants:a comparison with fluvoxamine. Adv Pharmacother 1986; 2:133–50.Google Scholar
6.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed (revised). Washington DC: American Psychiatric Association, 1987.Google Scholar
7.Robinson, JF, Doogan, DP. A placebo controlled study of the cardiovascular effects of fluvoxamine and clovoxamine in human volunteers. British Journal of Clin Pharmacol 1982; 14:805–8.CrossRefGoogle ScholarPubMed
8.Johnson, BA, McCann, J. Toxicity of lofepramine in heart disease. Ir J Psychol Med 1990;7:142–3.CrossRefGoogle Scholar